Metabolic dysfunction-associated steatotic liver disease (MASLD) is reportedly linked to rising cirrhosis in northern Mexico. The condition is also being studied globally, with research indicating potential links to various factors, including earlier menopause in women and urban health crises. The scope and impact of MASLD appear to be a growing concern, with the disease becoming a leading cause of cirrhosis in certain populations, although the full extent and trends of the issue are still being researched and analyzed.